Community Investing Ideas

Global Weekly Picks

CA$31.8
FV
98.5% undervalued intrinsic discount
4.4k
users have viewed this narrative
14users have liked this narrative
7users have commented on this narrative
45users have followed this narrative
PLX logo
Protalix BioTherapeutics

Protalix BioTherapeutics aims for $3.20 by year-end amidst strong revenue growth

As of right now the stock as a current yield of about 2.42%, with a return on equity of about 6.79%. So a bit off of my goals of at least 5% and 10%.Read more

View narrative
264
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
US$4.23
59.1% undervalued intrinsic discount
Zwfis's Fair Value
Revenue
14% p.a.
Profit Margin
20%
Future PE
29.15x
Price in 2028
US$5.11
AU$21.9
5.2% overvalued intrinsic discount
Robbo's Fair Value
Revenue
14.24% p.a.
Profit Margin
12.03%
Future PE
23.34x
Price in 2030
AU$43.53
AU$1.24
0% overvalued intrinsic discount
Robbo's Fair Value
Revenue
24.7% p.a.
Profit Margin
21.49%
Future PE
8.51x
Price in 2030
AU$4.91
AU$15
25.9% undervalued intrinsic discount
Robbo's Fair Value
Revenue
24.34% p.a.
Profit Margin
27.08%
Future PE
15.35x
Price in 2030
AU$30.74
US$38.61
69.5% undervalued intrinsic discount
BlackGoat's Fair Value
Revenue
13% p.a.
Profit Margin
10%
Future PE
28x
Price in 2029
US$76.73
SEK 300
51.5% undervalued intrinsic discount
Investingwilly's Fair Value
Revenue
32.58% p.a.
Profit Margin
16.31%
Future PE
9.74x
Price in 2029
SEK 558.32
US$237.43
29.4% overvalued intrinsic discount
Investingwilly's Fair Value
Revenue
18.03% p.a.
Profit Margin
27.74%
Future PE
25.45x
Price in 2029
US$512.49
SEK 100.02
10.6% undervalued intrinsic discount
Investingwilly's Fair Value
Revenue
20.27% p.a.
Profit Margin
35.29%
Future PE
61.72x
Price in 2029
SEK 183.34
US$152.63
18.6% overvalued intrinsic discount
Investingwilly's Fair Value
Revenue
34.85% p.a.
Profit Margin
55.85%
Future PE
33.98x
Price in 2028
US$267.69